Improving the objective quality of large-scale clinical trials for women with heavy menstrual bleeding: Experience from 2 multi-center, randomized trials

Reproductive Sciences

Volumn 20, Issue 7, 2013, Pages 745-754

  Fraser, Ian S ^a   Zeun, Susan ^b   Parke, Susanne ^b   Wilke, Baerbel ^c   Junge, Wolfgang ^c   Serrani, Marco ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b BAYER PHARMA AG   (Germany)

^c Laboratorium für Klinische Forschung   (Germany)

Author keywords

clinical trial methodology; heavy menstrual bleeding; menstrual blood collection; menstrual blood loss; menstrual blood quantification

Indexed keywords

DIENOGEST PLUS ESTRADIOL VALERATE; HEMOGLOBIN; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEAVY MENSTRUAL BLEEDING; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; MENSTRUATION DISORDER; MULTICENTER STUDY; PATIENT ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; TREATMENT OUTCOME;

CLINICAL TRIAL METHODOLOGY; HEAVY MENSTRUAL BLEEDING; MENSTRUAL BLOOD COLLECTION; MENSTRUAL BLOOD LOSS; MENSTRUAL BLOOD QUANTIFICATION;

CONTRACEPTIVES, ORAL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONALITY; MENORRHAGIA; NANDROLONE;

EID: 84878857105     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113477492     Document Type: Article

References (37)

1. Agency for Healthcare Research and Quality. Primary Care Management of Abnormal Uterine Bleeding (AUB). http://www.effectivehealthcare.ahrq.gov/index. cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct& productid=850. Accessed September 18, 2012.
2. Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO Recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011 ; 29 (5). 383-390
3. National Institute for Health and Clinical Excellence. Collaborating Centre for Women's and Children's Health. Heavy menstrual bleeding. http://guidance.nice.org.uk/CG44/Guidance/pdf/English. Accessed September 18, 2012.
4. Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?. Hum Reprod. 2007 ; 22 (3). 635-643
5. Fraser IS, Critchley HO, Munro MG, Broder M. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril. 2007 ; 87 (3). 466-476
6. Hallberg L, Hogdahl AM, Nilsson L, Rybo G.. Menstrual blood loss - a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand. 1966 ; 45 (3). 320-351
7. Fraser IS, Langham S, Uhl-Hochgraeber K. Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Rev Obstet Gynecol. 2009 ; 4 (2). 179-189
8. Janssen CA, Scholten PC, Heintz AP. Reconsidering menorrhagia in gynecological practice. Is a 30-year-old definition still valid?. Eur J Obstet Gynecol Reprod Biol. 1998 ; 78 (1). 69-72
9. Kadir RA, Aledort LM.. Obstetrical and gynaecological bleeding: a common presenting symptom. Clin Lab Haematol. 2000 ; 22 (suppl 1). 12-16
10. Hurskainen R, Grenman S, Komi I, et al. Diagnosis and treatment of menorrhagia. Acta Obstet Gynecol Scand. 2007 ; 86 (6). 749-757
11. El-Hemaidi I, Gharaibeh A, Shehata H. Menorrhagia and bleeding disorders. Curr Opin Obstet Gynecol. 2007 ; 19 (6). 513-520
12. James AH, Kouides PA, Abdul-Kadir R, et al. Evaluation and management of acute menorrhagia in women with and without underlying bleeding disorders: consensus from an international expert panel. Eur J Obstet Gynecol Reprod Biol. 2011 ; 158 (2). 124-134
13. King R, Overton C. Management of fibroids should be tailored to the patient. Practitioner. 2011 ; 255 (1738). 19-23
14. Marjoribanks J, Lethaby A, Farquhar C.. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006;(2) ;: CD003855
15. Beaumont H, Augood C, Duckitt K, Lethaby A.. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev. 2007 ;: CD001017
16. Lethaby A, Augood C, Duckitt K, Farquhar C.. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2007 ;: CD000400
17. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(4) ;: CD000249
18. Lethaby A, Irvine G, Cameron I.. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev.: CD001016
19. Lethaby A, Cooke I, Rees M.. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev.: CD002126
20. Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol. 1991 ; 31 (1). 66-70
21. Farquhar C, Brown J.. Oral contraceptive pill for heavy menstrual bleeding. Cochrane Database Syst Rev. 2009 ;: CD000154
22. Shabaan MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception. 2010 ; 83 (1). 48-54
23. Efficacy and safety study for the treatment of dysfunctional uterine bleeding. http://clinicaltrials.gov/ct2/show/NCT00293059?term= NCT00293059&rank=1. Accessed September 19, 2012.
24. Efficacy and safety study for the treatment of dysfunctional uterine bleeding. http://clinicaltrials.gov/ct2/show/NCT00307801?term= NCT00307801&rank=1. Accessed September 19, 2012.
25. Fraser I, Parke S, Mellinger U, Machlitt A, Serrani M, Jensen J. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care. 2011 ; 16 (4). 258-269
26. Jensen JP, Mellinger U, Machlitt A, Fraser IS
27. Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol. 2001 ; 98 (5 Pt 1). 806-814
28. Rees MC, Cederholm-Williams SA, Turnbull AC. Coagulation factors and fibrinolytic proteins in menstrual fluid collected from normal and menorrhagic women. Br J Obstet Gynaecol. 1985 ; 92 (11). 1164-1168
29. Baldwin RM, Whalley PJ, Pritchard JA.. Measurements of menstrual blood loss. Am J Obstet Gynecol. 1961 ; 81: 739-742
30. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990 ; 97 (8). 734-739
31. van Eijkeren MA, Scholten PC, Christiaens GC, Alsbach GP, Haspels AA. The alkaline hematin method for measuring menstrual blood loss - a modification and its clinical use in menorrhagia. Eur J Obstet Gynecol Reprod Biol. 1986 ; 22 (5-6). 345-351
32. Hallberg L, Nilsson L.. Determination of menstrual blood loss. Scand J Clin Lab Invest. 1964 ; 16: 244-248
33. Shaw ST, Aaronson DE, Moyer DL. Quantitation of menstrual blood loss - further evaluation of the alkaline hematin method. Contraception. 1972 ; 5 (6). 497-513
34. Moharram NM, El Aouad R, Al Busaidy S, et al. International collaborative assessment study of the AHD575 method for the measurement of blood haemoglobin. East Mediterr Health J. 2006 ; 12 (6). 722-734
35. Heuck CC, Reinauer H, Wood WG. The alkaline haematin detergent (AHD575) method for the determination of haemoglobin in blood - a candidate reference measurement procedure. Clin Lab. 2008 ; 54 (7-8). 255-272
36. Jensen J, Parke S, Mellinger U, Machlitt A, Fraser I. Effective treatment of heavy menstrual bleeding with estradiol valerate. Obstet Gynecol. 2011 ; 117 (4). 777-787
37. Fraser IS, Römer T, Parke S. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing oestradiol valerate and dienogest: a randomised, double-blind Phase III trial. Hum Reprod. 2011 ; 26 (10). 2698-2708